Entero Therapeutics Statistics
Total Valuation
ENTO has a market cap or net worth of $1.79 million. The enterprise value is $1.77 million.
Important Dates
The next estimated earnings date is Tuesday, May 20, 2025, before market open.
| Earnings Date | May 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ENTO has 4.77 million shares outstanding. The number of shares has increased by 921.26% in one year.
| Current Share Class | 4.77M |
| Shares Outstanding | 4.77M |
| Shares Change (YoY) | +921.26% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.86% |
| Owned by Institutions (%) | 1.82% |
| Float | 4.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.03 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.03, with a Debt / Equity ratio of 0.00.
| Current Ratio | 3.03 |
| Quick Ratio | 0.01 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -50.87% and return on invested capital (ROIC) is -31.31%.
| Return on Equity (ROE) | -50.87% |
| Return on Assets (ROA) | -21.16% |
| Return on Invested Capital (ROIC) | -31.31% |
| Return on Capital Employed (ROCE) | -27.00% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$9.15M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.40% in the last 52 weeks. The beta is 0.89, so ENTO's price volatility has been lower than the market average.
| Beta (5Y) | 0.89 |
| 52-Week Price Change | -88.40% |
| 50-Day Moving Average | 0.48 |
| 200-Day Moving Average | 0.54 |
| Relative Strength Index (RSI) | 40.42 |
| Average Volume (20 Days) | 1,399,708 |
Short Selling Information
The latest short interest is 122,705, so 2.57% of the outstanding shares have been sold short.
| Short Interest | 122,705 |
| Short Previous Month | 142,747 |
| Short % of Shares Out | 2.57% |
| Short % of Float | 2.62% |
| Short Ratio (days to cover) | 0.23 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -15.62M |
| Pretax Income | n/a |
| Net Income | -18.30M |
| EBITDA | -15.61M |
| EBIT | -15.62M |
| Earnings Per Share (EPS) | -$5.33 |
Full Income StatementBalance Sheet
The company has $163,476 in cash and $140,534 in debt, giving a net cash position of $22,942 or $0.00 per share.
| Cash & Cash Equivalents | 163,476 |
| Total Debt | 140,534 |
| Net Cash | 22,942 |
| Net Cash Per Share | $0.00 |
| Equity (Book Value) | 57.80M |
| Book Value Per Share | -0.82 |
| Working Capital | 55.93M |
Full Balance SheetCash Flow
| Operating Cash Flow | -9.22M |
| Capital Expenditures | n/a |
| Free Cash Flow | -9.22M |
| FCF Per Share | -$1.93 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |